-
1
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., Kirby A., Sourjina T., Peto R., Collins R., and Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
-
(2005)
Lancet
, vol.366
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
Blackwell, L.4
Buck, G.5
Pollicino, C.6
Kirby, A.7
Sourjina, T.8
Peto, R.9
Collins, R.10
Simes, R.11
-
2
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto Jr. A.M., Kastelein J.J., Koenig W., Libby P., Lorenzatti A.J., MacFadyen J.G., Nordestgaard B.G., Shepherd J., Willerson J.T., and Glynn R.J. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008) 2195-2207
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
Genest, J.4
Gotto Jr., A.M.5
Kastelein, J.J.6
Koenig, W.7
Libby, P.8
Lorenzatti, A.J.9
MacFadyen, J.G.10
Nordestgaard, B.G.11
Shepherd, J.12
Willerson, J.T.13
Glynn, R.J.14
-
3
-
-
33645524176
-
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial
-
Nissen S.E., Nicholls S.J., Sipahi I., Libby P., Raichlen J.S., Ballantyne C.M., Davignon J., Erbel R., Fruchart J.C., Tardif J.C., Schoenhagen P., Crowe T., Cain V., Wolski K., Goormastic M., and Tuzcu E.M. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
-
(2006)
JAMA
, vol.295
, pp. 1556-1565
-
-
Nissen, S.E.1
Nicholls, S.J.2
Sipahi, I.3
Libby, P.4
Raichlen, J.S.5
Ballantyne, C.M.6
Davignon, J.7
Erbel, R.8
Fruchart, J.C.9
Tardif, J.C.10
Schoenhagen, P.11
Crowe, T.12
Cain, V.13
Wolski, K.14
Goormastic, M.15
Tuzcu, E.M.16
-
4
-
-
0027969228
-
Serum total cholesterol and mortality in a Japanese population
-
Iso H., Naito Y., Kitamura A., Sato S., Kiyama M., Takayama Y., Iida M., Shimamoto T., Sankai T., and Komachi Y. Serum total cholesterol and mortality in a Japanese population. J Clin Epidemiol 47 (1994) 961-969
-
(1994)
J Clin Epidemiol
, vol.47
, pp. 961-969
-
-
Iso, H.1
Naito, Y.2
Kitamura, A.3
Sato, S.4
Kiyama, M.5
Takayama, Y.6
Iida, M.7
Shimamoto, T.8
Sankai, T.9
Komachi, Y.10
-
5
-
-
0026681128
-
Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial
-
Neaton J.D., Blackburn H., Jacobs D., Kuller L., Lee D.J., Sherwin R., Shih J., Stamler J., and Wentworth D. Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 152 (1992) 1490-1500
-
(1992)
Arch Intern Med
, vol.152
, pp. 1490-1500
-
-
Neaton, J.D.1
Blackburn, H.2
Jacobs, D.3
Kuller, L.4
Lee, D.J.5
Sherwin, R.6
Shih, J.7
Stamler, J.8
Wentworth, D.9
-
6
-
-
0025828611
-
Serum cholesterol and mortality among Japanese-American men
-
Honolulu (Hawaii) Heart Program
-
Stemmermann G.N., Chyou P.H., Kagan A., Nomura A.M., Yano K., and Honolulu (Hawaii) Heart Program. Serum cholesterol and mortality among Japanese-American men. Arch Intern Med 151 (1991) 969-972
-
(1991)
Arch Intern Med
, vol.151
, pp. 969-972
-
-
Stemmermann, G.N.1
Chyou, P.H.2
Kagan, A.3
Nomura, A.M.4
Yano, K.5
-
7
-
-
34547970751
-
Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the Treating to New Targets [TNT] study)
-
LaRosa J.C., Grundy S.M., Kastelein J.J., Kostis J.B., and Greten H. Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the Treating to New Targets [TNT] study). Am J Cardiol 100 (2007) 747-752
-
(2007)
Am J Cardiol
, vol.100
, pp. 747-752
-
-
LaRosa, J.C.1
Grundy, S.M.2
Kastelein, J.J.3
Kostis, J.B.4
Greten, H.5
-
8
-
-
26844468578
-
Can low-density lipoprotein be too low?. The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy
-
Wiviott S.D., Cannon C.P., Morrow D.A., Ray K.K., Pfeffer M.A., and Braunwald E. Can low-density lipoprotein be too low?. The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol 46 (2005) 1411-1416
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1411-1416
-
-
Wiviott, S.D.1
Cannon, C.P.2
Morrow, D.A.3
Ray, K.K.4
Pfeffer, M.A.5
Braunwald, E.6
-
9
-
-
33746895436
-
High-dose atorvastatin after stroke or transient ischemic attack
-
Amarenco P., Bogousslavsky J., Callahan III A., Goldstein L.B., Hennerici M., Rudolph A.E., Sillesen H., Simunovic L., Szarek M., Welch K.M., and Zivin J.A. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
-
(2006)
N Engl J Med
, vol.355
, pp. 549-559
-
-
Amarenco, P.1
Bogousslavsky, J.2
Callahan III, A.3
Goldstein, L.B.4
Hennerici, M.5
Rudolph, A.E.6
Sillesen, H.7
Simunovic, L.8
Szarek, M.9
Welch, K.M.10
Zivin, J.A.11
-
10
-
-
4544275379
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., Pasternak R.C., Smith Jr. S.C., and Stone N.J. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol 44 (2004) 720-732
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 720-732
-
-
Grundy, S.M.1
Cleeman, J.I.2
Merz, C.N.3
Brewer Jr., H.B.4
Clark, L.T.5
Hunninghake, D.B.6
Pasternak, R.C.7
Smith Jr., S.C.8
Stone, N.J.9
-
11
-
-
34250618645
-
Safety and efficacy of very low LDL-C levels: a post-hoc analysis of the TNT study
-
LaRosa J.C., SM G., Kastelein J.J., and JB K. Safety and efficacy of very low LDL-C levels: a post-hoc analysis of the TNT study. Circulation 112 (2005) 662-663
-
(2005)
Circulation
, vol.112
, pp. 662-663
-
-
LaRosa, J.C.1
SM, G.2
Kastelein, J.J.3
JB, K.4
-
12
-
-
0037226969
-
Effects of statins in reducing thrombotic risk and modulating plaque vulnerability
-
Libby P., and Aikawa M. Effects of statins in reducing thrombotic risk and modulating plaque vulnerability. Clin Cardiol 26 (2003) 11-14
-
(2003)
Clin Cardiol
, vol.26
, pp. 11-14
-
-
Libby, P.1
Aikawa, M.2
-
13
-
-
33748064338
-
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor trial
-
Morrow D.A., de Lemos J.A., Sabatine M.S., Wiviott S.D., Blazing M.A., Shui A., Rifai N., Califf R.M., and Braunwald E. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor trial. Circulation 114 (2006) 281-288
-
(2006)
Circulation
, vol.114
, pp. 281-288
-
-
Morrow, D.A.1
de Lemos, J.A.2
Sabatine, M.S.3
Wiviott, S.D.4
Blazing, M.A.5
Shui, A.6
Rifai, N.7
Califf, R.M.8
Braunwald, E.9
-
14
-
-
11344279659
-
C-reactive protein levels and outcomes after statin therapy
-
Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., Pfeffer M.A., and Braunwald E. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
-
(2005)
N Engl J Med
, vol.352
, pp. 20-28
-
-
Ridker, P.M.1
Cannon, C.P.2
Morrow, D.3
Rifai, N.4
Rose, L.M.5
McCabe, C.H.6
Pfeffer, M.A.7
Braunwald, E.8
-
15
-
-
36249022736
-
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein
-
Ridker P.M., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., Khurmi N.S., Koenig W., Libby P., Lorenzatti A.J., Nordestgaard B.G., Shepherd J., Willerson J.T., and Glynn R.J. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. Am J Cardiol 100 (2007) 1659-1664
-
(2007)
Am J Cardiol
, vol.100
, pp. 1659-1664
-
-
Ridker, P.M.1
Fonseca, F.A.2
Genest, J.3
Gotto, A.M.4
Kastelein, J.J.5
Khurmi, N.S.6
Koenig, W.7
Libby, P.8
Lorenzatti, A.J.9
Nordestgaard, B.G.10
Shepherd, J.11
Willerson, J.T.12
Glynn, R.J.13
-
16
-
-
0036715223
-
ACC/AHA/NHLBI clinical advisory on the use and safety of statins
-
Pasternak R.C., Smith Jr. S.C., Bairey-Merz C.N., Grundy S.M., Cleeman J.I., and Lenfant C. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Stroke 33 (2002) 2337-2341
-
(2002)
Stroke
, vol.33
, pp. 2337-2341
-
-
Pasternak, R.C.1
Smith Jr., S.C.2
Bairey-Merz, C.N.3
Grundy, S.M.4
Cleeman, J.I.5
Lenfant, C.6
-
17
-
-
0037150209
-
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project
-
Pfeffer M.A., Keech A., Sacks F.M., Cobbe S.M., Tonkin A., Byington R.P., Davis B.R., Friedman C.P., and Braunwald E. Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project. Circulation 105 (2002) 2341-2346
-
(2002)
Circulation
, vol.105
, pp. 2341-2346
-
-
Pfeffer, M.A.1
Keech, A.2
Sacks, F.M.3
Cobbe, S.M.4
Tonkin, A.5
Byington, R.P.6
Davis, B.R.7
Friedman, C.P.8
Braunwald, E.9
-
18
-
-
0041526376
-
Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients
-
Newman C.B., Palmer G., Silbershatz H., and Szarek M. Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients. Am J Cardiol 92 (2003) 670-676
-
(2003)
Am J Cardiol
, vol.92
, pp. 670-676
-
-
Newman, C.B.1
Palmer, G.2
Silbershatz, H.3
Szarek, M.4
-
19
-
-
5344244695
-
Safety of rosuvastatin
-
Shepherd J., Hunninghake D.B., Stein E.A., Kastelein J.J., Harris S., Pears J., and Hutchinson H.G. Safety of rosuvastatin. Am J Cardiol 94 (2004) 882-888
-
(2004)
Am J Cardiol
, vol.94
, pp. 882-888
-
-
Shepherd, J.1
Hunninghake, D.B.2
Stein, E.A.3
Kastelein, J.J.4
Harris, S.5
Pears, J.6
Hutchinson, H.G.7
-
20
-
-
34248223741
-
Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program
-
Shepherd J., Vidt D.G., Miller E., Harris S., and Blasetto J. Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program. Cardiology 107 (2007) 433-443
-
(2007)
Cardiology
, vol.107
, pp. 433-443
-
-
Shepherd, J.1
Vidt, D.G.2
Miller, E.3
Harris, S.4
Blasetto, J.5
-
21
-
-
15944410609
-
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
-
LaRosa J.C., Grundy S.M., Waters D.D., Shear C., Barter P., Fruchart J.C., Gotto A.M., Greten H., Kastelein J.J., Shepherd J., and Wenger N.K. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352 (2005) 1425-1435
-
(2005)
N Engl J Med
, vol.352
, pp. 1425-1435
-
-
LaRosa, J.C.1
Grundy, S.M.2
Waters, D.D.3
Shear, C.4
Barter, P.5
Fruchart, J.C.6
Gotto, A.M.7
Greten, H.8
Kastelein, J.J.9
Shepherd, J.10
Wenger, N.K.11
-
22
-
-
11144355354
-
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
-
Cannon C.P., Braunwald E., McCabe C.H., Rader D.J., Rouleau J.L., Belder R., Joyal S.V., Hill K.A., Pfeffer M.A., and Skene A.M. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
-
(2004)
N Engl J Med
, vol.350
, pp. 1495-1504
-
-
Cannon, C.P.1
Braunwald, E.2
McCabe, C.H.3
Rader, D.J.4
Rouleau, J.L.5
Belder, R.6
Joyal, S.V.7
Hill, K.A.8
Pfeffer, M.A.9
Skene, A.M.10
-
23
-
-
43449113279
-
Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden
-
Ballantyne C.M., Raichlen J.S., Nicholls S.J., Erbel R., Tardif J.C., Brener S.J., Cain V.A., and Nissen S.E. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation 117 (2008) 2458-2466
-
(2008)
Circulation
, vol.117
, pp. 2458-2466
-
-
Ballantyne, C.M.1
Raichlen, J.S.2
Nicholls, S.J.3
Erbel, R.4
Tardif, J.C.5
Brener, S.J.6
Cain, V.A.7
Nissen, S.E.8
|